CKD 5
The percentage of patients on the CKD register with hypertension and proteinuria who are treated with an angiotensin coverting enzyme inhibitor (ACE-I) or angiotensin receptor blocker (AEB) (unless a contraindication or side effects are recorded)
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| CKD 4 | 2007 | 111 | 130 | 85.4% | |
| CKD 4 | 2008 | 233 | 289 | 80.6% | |
| CKD 5 | 2009 | 52 | 60 | 86.7% | |
| CKD 5 | 2010 | 19 | 23 | 82.6% | |
| CKD 5 | 2011 | 40 | 50 | 80.0% | |
| CKD 5 | 2012 | 46 | 51 | 90.2% | |
| CKD 5 | 2013 | 51 | 55 | 92.7% | |
| CKD003 | 2014 | 46 | 58 | 79.3% | |
| CKD003 | 2015 | 34 | 40 | 85.0% | |
| CKD003 | 2016 | 45 | 50 | 90.0% |
